Which method of determining MGMT promoter methylation best predicts survival in people with glioblastoma treated with temozolomide?
In March 2021, the Cochrane Neuro-Oncology Group published a series of eight new systematic reviews on priority topics for the brain tumour community. These were selected from the most important unanswered questions identified by patients, the public and practitioners. In this podcast, Kathreena Kurian from the University of Bristol in the UK tells us about one of the reviews, which looked at the evidence on tests that might help to predict survival in patients who have received chemotherapy for glioblastoma. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 27, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts

Final Results of the TAVAREC Trial: Temozolomide with or without Bevacizumab in Glioma
Daniela Bota, MD of UC Irvine Health gives an overview of the final results of the TAVAREC trial, which studied temozolomide and bevacizumab in patients with glioma. This was recorded at the 2017 MOAS... Author: moasc Added: 08/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2017 Category: Cancer & Oncology Source Type: podcasts

Maintenance Therapy After Chemoradiation in Patients With Glioblastoma
Interview with Roger Stupp, MD, author of Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 15, 2015 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

ASCO 2013 - Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) - Dr. Richard Carvajal
Video interview with Dr. Richard Carvajal Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) at ASCO 2013. Author: oncologyeducation Added: 06/23/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2013 Category: Cancer & Oncology Source Type: podcasts